No
|
TR-074
|
79-00-5 |
1,1,2-Trichloroethane |
Rats |
Osborne Mendel |
Female |
Gavage |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-074
|
79-00-5 |
1,1,2-Trichloroethane |
Rats |
Osborne Mendel |
Male |
Gavage |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
Yes
|
TR-074
|
79-00-5 |
1,1,2-Trichloroethane |
Mice |
B6C3F1 |
Female |
Gavage |
Adrenal Gland Medulla
|
Positive |
Positive |
PHEOCHROMOCYTOMA
|
Neoplastic Lesions
|
Yes
|
TR-074
|
79-00-5 |
1,1,2-Trichloroethane |
Mice |
B6C3F1 |
Male |
Gavage |
Adrenal Gland Medulla
|
Positive |
Positive |
PHEOCHROMOCYTOMA
|
Neoplastic Lesions
|
No
|
TR-074
|
79-00-5 |
1,1,2-Trichloroethane |
Mice |
B6C3F1 |
Female |
Gavage |
Liver
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-074
|
79-00-5 |
1,1,2-Trichloroethane |
Mice |
B6C3F1 |
Male |
Gavage |
Liver
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
Yes
|
TR-319
|
106-46-7 |
1,4-Dichlorobenzene (p-dichlorobenzene) |
Mice |
B6C3F1 |
Male |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 0/47 2/48 4/49
|
May Have Been Related
|
No
|
TR-319
|
106-46-7 |
1,4-Dichlorobenzene (p-dichlorobenzene) |
Rats |
F344/N |
Male |
Gavage |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
ADENOCARCINOMA 1/50 3/50 7/50
|
Neoplastic Lesions
|
No
|
TR-319
|
106-46-7 |
1,4-Dichlorobenzene (p-dichlorobenzene) |
Mice |
B6C3F1 |
Female |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 10/50 6/48 21/50; CARCINOMA 5/50 5/48 19/50
|
Neoplastic Lesions
|
No
|
TR-319
|
106-46-7 |
1,4-Dichlorobenzene (p-dichlorobenzene) |
Mice |
B6C3F1 |
Male |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 5/50 13/49 16/50; CARCINOMA 14/50 11/49 32/50
|
Neoplastic Lesions
|
No
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Mice |
B6C3F1 |
Male |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
Yes
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Rats |
F344/N |
Female |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 1/50 5/50 6/50
|
Neoplastic Lesions
|
Yes
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 18/50 25/50 22/49 OR MALIGNANT PHEOCHROMOCYTOMA 0/50 2/50 2/49 COMBINED 18/50 27/50 24/49
|
Neoplastic Lesions
|
No
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Rats |
F344/N |
Male |
Gavage |
Hematopoietic System
|
Some Evidence |
Some Evidence |
LEUKEMIA 7/50 16/50 3/50
|
Neoplastic Lesions
|
No
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Mice |
B6C3F1 |
Female |
Gavage |
Liver
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA 3/50 7/49 4/50 OR CARCINOMA 1/50 5/49 0/50 COMBINED 4/50 12/49 4/50
|
Neoplastic Lesions
|
No
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Rats |
F344/N |
Male |
Gavage |
Pancreas Acinar Cell
|
Some Evidence |
Some Evidence |
ADENOMA 2/50 13/50 6/50
|
Neoplastic Lesions
|
No
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Rats |
F344/N |
Female |
Gavage |
Pituitary Gland
|
Some Evidence |
Some Evidence |
ADENOMA 15/49 24/50 25/50
|
Neoplastic Lesions
|
No
|
TR-332
|
149-30-4 |
2-Mercaptobenzothiazole |
Rats |
F344/N |
Male |
Gavage |
Preputial Gland
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 4/50 4/50 OR CARCINOMA 1/50 2/50 1/50 COMBINED 1/50 6/50 5/50
|
Neoplastic Lesions
|
No
|
TR-085
|
5131-60-2 |
4-Chloro-m-phenylenediamine |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
No
|
TR-085
|
5131-60-2 |
4-Chloro-m-phenylenediamine |
Rats |
F344/N |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
Yes
|
TR-085
|
5131-60-2 |
4-Chloro-m-phenylenediamine |
Rats |
F344/N |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Positive |
Positive |
PHEOCHROMOCYTOMA
|
Neoplastic Lesions
|
No
|
TR-085
|
5131-60-2 |
4-Chloro-m-phenylenediamine |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Positive |
Positive |
(ADENOMA OR CARCINOMA)
|
Neoplastic Lesions
|
Yes
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Mice |
B6C3F1 |
Male |
Dosed-Water |
Adrenal Gland Medulla
|
Positive |
Positive |
PHEOCHROMOCYTOMA 2/48 12/49 14/49
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Water |
Hematopoietic System
|
Positive |
Positive |
LYMPHOMA 13/50 28/50 29/50
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Water |
Liver
|
Positive |
Positive |
ADENOMA 3/50 9/50 12/50
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Mice |
B6C3F1 |
Male |
Dosed-Water |
Liver
|
Positive |
Positive |
CARCINOMA 10/49 33/50 29/50
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Rats |
F344/N |
Male |
Dosed-Water |
Liver
|
Positive |
Positive |
NEOPLASTIC NODULE 1/50 12/50 25/50
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Rats |
F344/N |
Female |
Dosed-Water |
Thyroid Gland C-Cell
|
Positive |
Positive |
ADENOMA 0/47 3/47 6/48
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Water |
Thyroid Gland Follicular Cell
|
Positive |
Positive |
ADENOMA 0/50 1/47 13/50
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Mice |
B6C3F1 |
Male |
Dosed-Water |
Thyroid Gland Follicular Cell
|
Positive |
Positive |
ADENOMA 0/47 3/49 16/49
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Rats |
F344/N |
Female |
Dosed-Water |
Thyroid Gland Follicular Cell
|
Positive |
Positive |
ADENOMA 0/47 2/47 17/48
|
Neoplastic Lesions
|
No
|
TR-248
|
13552-44-8 |
4,4'-Methylenedianiline dihydrochloride |
Rats |
F344/N |
Male |
Dosed-Water |
Thyroid Gland Follicular Cell
|
Positive |
Positive |
CARCINOMA 0/49 0/47 7/48
|
Neoplastic Lesions
|
No
|
TR-570
|
76231-76-0 |
alpha/beta Thujone mixture |
Mice |
B6C3F1/N |
Female |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-570
|
76231-76-0 |
alpha/beta Thujone mixture |
Mice |
B6C3F1/N |
Male |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
Yes
|
TR-570
|
76231-76-0 |
alpha/beta Thujone mixture |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Equivocal Evidence |
Benign pheochromocytoma 6/50 850 12/49
|
May Have Been Related
|
No
|
TR-570
|
76231-76-0 |
alpha/beta Thujone mixture |
Rats |
F344/N |
Male |
Gavage |
Preputial Gland
|
Some Evidence |
Some Evidence |
Carcinoma 1/49 0/49 5/50; adenoma or carcinoma 3/49 1/49 9/50
|
Neoplastic Lesions
|
Yes
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Rats |
Wistar Han |
Female |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
benign pheochromocytoma (0/49, 2/49, 2/49, 6/50); benign or malignant pheochromocytoma (0/49, 2/49, 2/49, 7/50)
|
Neoplastic Lesions
|
Yes
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Rats |
Wistar Han |
Male |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
benign pheochromocytoma (1/49, 0/50, 2/49, 7/50)
|
Neoplastic Lesions
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Mice |
B6C3F1 |
Female |
Inhalation |
All Organs
|
Clear Evidence |
Clear Evidence |
malignant lymphoma (7/50, 17/50, 20/50, 27/50)
|
Neoplastic Lesions
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Rats |
Wistar Han |
Female |
Inhalation |
Lung
|
Some Evidence |
Equivocal Evidence |
cystic keratinizing epithelioma or squamous cell carcinoma (0/50, 0/50, 0/50, 3/50)
|
May Have Been Related
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Mice |
B6C3F1 |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma (1/50, 10/50, 19/50, 8/50); alveolar/bronchiolar carcinoma (2/50, 14/50, 11/50, 11/50); alveolar/bronchiolar adenoma or carcinoma (3/50, 22/50, 27/50, 18/50)
|
Neoplastic Lesions
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Mice |
B6C3F1 |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar carcinoma (4/50, 18/50, 20/50, 27/50)
|
Neoplastic Lesions
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Rats |
Wistar Han |
Female |
Inhalation |
Lung
|
Some Evidence |
Some Evidence |
alveolar/bronchiolar adenoma (0/50, 2/50, 6/50, 5/50)
|
Neoplastic Lesions
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Rats |
Wistar Han |
Male |
Inhalation |
Lung
|
Some Evidence |
Some Evidence |
alveolar/bronchiolar adenoma (3/50, 4/50, 6/50, 8/50); alveolar/bronchiolar adenoma or carcinoma (3/50, 4/50, 8/50, 8/50)
|
Neoplastic Lesions
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Mice |
B6C3F1 |
Female |
Inhalation |
Skin
|
Clear Evidence |
Equivocal Evidence |
squamous cell carcinoma (0/50, 0/50, 0/50, 2/50)
|
May Have Been Related
|
No
|
TR-590
|
1309-64-4 |
Antimony Trioxide |
Mice |
B6C3F1 |
Male |
Inhalation |
Skin
|
Clear Evidence |
Clear Evidence |
fibrous histiocytoma (0/50, 1/50, 1/50, 4/50); fibrous histiocytoma or fibrosarcoma (0/50, 1/50, 3/50, 4/50)
|
Neoplastic Lesions
|
Yes
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 8/48 23/47 17/50 21/49 OR MALIGNANT PHEOCHROMOCYTOMA 0/48 1/47 2/50 0/49 COMBINED 8/48 23/47 18/50 21/49
|
Neoplastic Lesions
|
No
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Rats |
F344/N |
Male |
Inhalation |
Brain
|
Some Evidence |
Equivocal Evidence |
GRANULAR CELL TUMOR 0/49 3/50 1/50 1/50; GLIOMA 0/49 1/50 0/50 0/50, ASTROCYTOMA 0/49 1/50 0/50 0/50, OR OLIGODENDROGLIOMA 0/49 1/50 0/50 0/50 COMBINED 0/49 3/50 0/50 0/50
|
May Have Been Related
|
No
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Rats |
F344/N |
Female |
Inhalation |
Brain
|
Equivocal Evidence |
Equivocal Evidence |
GLIOMA 0/50 1/50 1/48 3/50
|
Neoplastic Lesions
|
No
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Rats |
F344/N |
Male |
Inhalation |
Lung
|
Some Evidence |
Equivocal Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/48 0/49 1/48 1/48 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/48 0/49 3/48 0/48 COMBINED 0/48 0/49 4/48 1/48
|
May Have Been Related
|
No
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Mice |
B6C3F1 |
Male |
Inhalation |
Lung
|
Equivocal Evidence |
Equivocal Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 5/50 6/50 8/50 9/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 2/50 0/50 5/50 6/50 COMBINED 7/50 6/50 12/50 15/50
|
Neoplastic Lesions
|
No
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Equivocal Evidence |
Equivocal Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 0/48 0/47 3/49
|
Neoplastic Lesions
|
No
|
TR-363
|
74-96-4 |
Bromoethane (ethyl bromide) |
Mice |
B6C3F1 |
Female |
Inhalation |
Uterus/Cervix
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 1/50 1/47 6/48, ADENOCARCINOMA 0/50 2/50 3/47 19/48, OR SQUAMOUS CELL CARCINOMA 0/50 1/50 1/47 3/48 COMBINED 0/50 4/50 5/47 27/48
|
Neoplastic Lesions
|
Yes
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 1/50 3/35 5/64 1/50
|
May Have Been Related
|
Yes
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Male |
Dosed-Water |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 16/50 11/35 24/63 19/49 OR MALIGNANT PHEOCHROMOCYTOMA 2/50 0/35 3/63 2/49 COMBINED 17/50 11/35 27/63 21/49
|
May Have Been Related
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Clitoral Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 7/48 10/32 10/62 10/50, CARCINOMA 4/48 9/32 19/62 15/50, COMBINED 11/48 17/32 28/62 23/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Hematopoietic System
|
Clear Evidence |
Equivocal Evidence |
MONONUCLEAR CELL LEUKEMIA 12/50 13/35 18/65 5/50
|
May Have Been Related
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Intestines (Large)
|
Clear Evidence |
Clear Evidence |
NEOPLASMS 0/50 1/35 0/65 3/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Intestines (Small)
|
Clear Evidence |
Clear Evidence |
NEOPLASMS 0/50 0/35 1/65 2/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
NEOPLASTIC NODULE 0/50 0/35 15/64 6/50, CARCINOMA 0/50 0/35 6/64 3/50, COMBINED 0/50 0/35 19/64 8/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Male |
Dosed-Water |
Liver
|
Clear Evidence |
Clear Evidence |
NEOPLASTIC NODULE 2/50 1/35 10/65 15/50, CARCINOMA 0/50 1/35 6/65 7/50, COMBINED 2/50 2/35 15/65 20/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Male |
Dosed-Water |
Lung
|
Clear Evidence |
Equivocal Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 2/35 1/65 3/50, ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 0/35 1/65 0/50, COMBINED 2/50 2/35 2/65 3/50
|
May Have Been Related
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 1/50 2/35 8/65 4/50, ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 0/35 1/65 0/50, COMBINED 1/50 2/35 9/65 4/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Mammary Gland
|
Clear Evidence |
Equivocal Evidence |
ADENOCARCINOMA 0/50 3/35 6/65 3/50
|
May Have Been Related
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Male |
Dosed-Water |
Oral Cavity
|
Clear Evidence |
Equivocal Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 0/35 1/65 2/50
|
May Have Been Related
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Oral Cavity
|
Clear Evidence |
Clear Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 3/35 6/65 4/50, SQUAMOUS CELL CARCINOMA 0/50 0/35 3/65 2/50, COMBINED 0/50 3/35 9/65 6/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
BASAL CELL ADENOMA 0/50 3/35 5/65 3/50, BASAL CELL CARCINOMA 0/50 1/35 2/65 2/50, COMBINED 0/50 4/35 7/65 5/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Male |
Dosed-Water |
Skin
|
Clear Evidence |
Clear Evidence |
BASAL CELL ADENOMA 1/50 4/35 26/65 30/50, BASAL CELL CARCINOMA 0/50 1/35 5/65 6/50, COMBINED 1/50 5/35 28/65 32/50; KERATOACANTHOMA 1/50 1/35 4/65 7/50; SEBACEOUS GLAND ADENOMA 0/50 1/35 5/65 5/50, SEBACEOUS GLAND CARCINOMA 1/50 0/35 0/65 1/50, COMBINED 1/50 1/35 5/65 6/50; SQUAMOUS CELL PAPILLOMA 1/50 0/35 3/65 2/50, SQUAMOUS CELL CARCINOMA 0/50 2/35 8/65 7/50, COMBINED 1/50 2/35 11/65 9/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Female |
Dosed-Water |
Zymbal Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 0/35 2/65 6/50, CARCINOMA 0/50 3/35 17/65 13/50, COMBINED 0/50 3/35 18/65 19/50
|
Neoplastic Lesions
|
No
|
TR-405
|
6459-94-5 |
C.I. Acid Red 114 |
Rats |
F344/N |
Male |
Dosed-Water |
Zymbal Gland
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 0/35 1/65 1/50, CARCINOMA 0/50 0/35 7/65 6/50, COMBINED 0/50 0/35 8/65 7/50
|
Neoplastic Lesions
|
Yes
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 1/48 7/47 7/45 OR MALIGNANT PHEOCHROMOCYTOMA 0/48 1/47 1/45 COMBINED 1/48 8/47 8/45
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Hematopoietic System
|
Clear Evidence |
Equivocal Evidence |
LYMPHOMA 17/50 24/50 25/50
|
May Have Been Related
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
CARCINOMA 3/49 19/50 37/49
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
CARCINOMA 10/50 20/50 27/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
CARCINOMA 0/50 2/50 8/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Mammary Gland
|
Clear Evidence |
Equivocal Evidence |
ADENOMA 0/50 3/50 1/50, FIBROADENOMA 22/50 31/50 29/50, OR ADENOCARCINOMA 2/50 2/50 5/50 COMBINED 23/50 32/50 32/50
|
May Have Been Related
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Skin
|
Clear Evidence |
Clear Evidence |
TRICHOEPITHELIOMA 0/50 0/50 7/50; SEBACEOUS ADENOMA 0/50 0/50 5/50; SQUAMOUS CELL CARCINOMA 0/50 1/50 10/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Subcutaneous Tissue
|
Clear Evidence |
Clear Evidence |
FIBROMA 0/50 15/50 10/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Subcutaneous Tissue
|
Clear Evidence |
Clear Evidence |
FIBROMA 2/50 20/50 16/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Thyroid Gland Follicular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/47 0/48 4/50 OR CARCINOMA 0/47 2/48 2/50 COMBINED 0/47 2/48 6/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Thyroid Gland Follicular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/49 0/46 9/44 OR CARCINOMA 0/49 5/46 18/44
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Female |
Dosed-Feed |
Zymbal Gland
|
Clear Evidence |
Clear Evidence |
CARCINOMA 0/50 2/50 7/50
|
Neoplastic Lesions
|
No
|
TR-285
|
569-61-9 |
C.I. Basic Red 9 Monohydrochloride |
Rats |
F344/N |
Male |
Dosed-Feed |
Zymbal Gland
|
Clear Evidence |
Clear Evidence |
CARCINOMA 1/50 1/50 13/50
|
Neoplastic Lesions
|
Yes
|
TR-407
|
2425-85-6 |
C.I. Pigment Red 3 |
Rats |
F344/N |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 24/50 32/50 37/50 36/50
|
Neoplastic Lesions
|
No
|
TR-407
|
2425-85-6 |
C.I. Pigment Red 3 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Kidney Tubular Cell
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 0/50 0/50 6/50
|
Neoplastic Lesions
|
No
|
TR-407
|
2425-85-6 |
C.I. Pigment Red 3 |
Rats |
F344/N |
Female |
Dosed-Feed |
Liver
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 0/50 1/50 10/50
|
Neoplastic Lesions
|
No
|
TR-407
|
2425-85-6 |
C.I. Pigment Red 3 |
Rats |
F344/N |
Male |
Dosed-Feed |
Skin
|
Some Evidence |
Equivocal Evidence |
SQUAMOUS CELL PAPILLOMA 0/50 4/50 2/50 6/50
|
May Have Been Related
|
No
|
TR-407
|
2425-85-6 |
C.I. Pigment Red 3 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Thyroid Gland Follicular Cell
|
Some Evidence |
Some Evidence |
ADENOMA 0/50 0/49 1/50 5/50
|
Neoplastic Lesions
|
No
|
TR-407
|
2425-85-6 |
C.I. Pigment Red 3 |
Rats |
F344/N |
Male |
Dosed-Feed |
Zymbal Gland
|
Some Evidence |
Equivocal Evidence |
CARCINOMA 0/50 0/50 2/50 3/50
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Female |
Whole Body Exposure |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
benign, malignant, or complex pheochromocytoma (1/86, 9/89, 5/87, 4/88)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Female |
Whole Body Exposure |
Brain
|
Equivocal Evidence |
Equivocal Evidence |
glioma malignant (0/90, 3/90, 0/90, 0/90)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Brain
|
Clear Evidence |
Clear Evidence |
glioma malignant (0/90, 0/90, 0/90, 3/90)
|
Neoplastic Lesions
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Female |
Whole Body Exposure |
Heart
|
Equivocal Evidence |
Equivocal Evidence |
schwannoma malignant (0/90, 2/90, 0/90, 2/90)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Heart
|
Clear Evidence |
Clear Evidence |
schwannoma malignant (0/90, 2/90, 3/90, 6/90)
|
Neoplastic Lesions
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Liver
|
Clear Evidence |
Equivocal Evidence |
hepatocellular adenoma or carcinoma (combined) (0/90, 2/90, 4/89, 1/88)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADCDMA |
Cell Phone Radiation: CDMA |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Pituitary Gland
|
Clear Evidence |
Equivocal Evidence |
pars distalis, adenoma (17/89, 25/90, 34/90, 13/90)
|
May Have Been Related
|
Yes
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
benign, malignant, or complex pheochromocytoma (11/88, 24/90, 28/89, 14/87)
|
Neoplastic Lesions
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Brain
|
Clear Evidence |
Equivocal Evidence |
meninges, granular cell tumor benign or malignant (1/90, 3/90, 4/90, 3/90)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Brain
|
Clear Evidence |
Clear Evidence |
glioma malignant (0/90, 3/90, 3/90, 2/90)
|
Neoplastic Lesions
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Female |
Whole Body Exposure |
Heart
|
Equivocal Evidence |
Equivocal Evidence |
schwannoma malignant (0/90, 0/90, 2/90, 0/90)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Heart
|
Clear Evidence |
Clear Evidence |
schwannoma malignant (0/90, 2/90, 1/90, 5/90)
|
Neoplastic Lesions
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Pancreas Islet Cell
|
Clear Evidence |
Equivocal Evidence |
adenoma or carcinoma (13/90, 27/89, 19/86, 16/85)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Pituitary Gland
|
Clear Evidence |
Equivocal Evidence |
pars distalis, adenoma (17/89, 28/90, 26/90, 26/90)
|
May Have Been Related
|
No
|
TR-595
|
CELLPRADGSM |
Cell Phone Radiation: GSM |
Rats |
Hsd:Sprague Dawley SD |
Male |
Whole Body Exposure |
Prostate Gland
|
Clear Evidence |
Equivocal Evidence |
adenoma or carcinoma (2/90, 2/90, 7/90, 3/90)
|
May Have Been Related
|
Yes
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Female |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
benign pheochromocytoma 6/50 12/50 22/50 36/50 malignant pheochromocytoma 0/50 2/50 3/50 11/50 benign or malignant pheochromocytoma 6/50 13/50 23/50 40/50
|
Neoplastic Lesions
|
Yes
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Male |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
benign pheochromocytoma 15/50 23/50 37/50 34/50 malignant pheochromocytoma 2/50 2/50 9/50 16/50 benign or malignant pheochromocytoma 17/50 23/50 38/50 41/50
|
Neoplastic Lesions
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Female |
Inhalation |
All Organs
|
Clear Evidence |
Clear Evidence |
Mononuclear Cell Leukemia 16/50 29/50 28/50 27/50
|
Neoplastic Lesions
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Male |
Inhalation |
Kidney
|
Clear Evidence |
Equivocal Evidence |
adenoma or carcinoma (standard evaluation) 0/50 1/50 0/50 4/50 (standard and extended evaluations combined) 3/50 1/50 1/50 7/50
|
May Have Been Related
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Mice |
B6C3F1/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Equivocal Evidence |
alveolar/bronchiolar adenoma 3/49 9/50 8/50 10/50 alveolar/bronchiolar carcinoma 5/49 25/50 38/50 43/50 alveolar/bronchiolar adenoma or carcinoma 8/49 30/50 41/50 45/50
|
May Have Been Related
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Male |
Inhalation |
Lung
|
Clear Evidence |
Equivocal Evidence |
cystic keratinizing epithelioma 0/50 1/50 0/50 1/50
|
May Have Been Related
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Mice |
B6C3F1/N |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma 7/50 11/49 15/50 3/50 alveolar/bronchiolar carcinoma 11/50 38/49 42/50 46/50 alveolar/bronchiolar adenoma or carcinoma 16/50 41/49 43/50 47/50
|
Neoplastic Lesions
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma 2/50 7/50 9/50 13/50 alveolar/bronchiolar carcinoma 0/50 9/50 17/50 30/50 alveolar/bronchiolar adenoma or carcinoma 2/50 15/50 20/50 38/50 cystic keratinizing epithelioma 0/50 4/50 1/50 2/50
|
Neoplastic Lesions
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
alveolar/bronchiolar adenoma 2/50 10/50 10/50 14/50 alveolar/bronchiolar carcinoma 0/50 16/50 34/50 36/50 alveolar/bronchiolar adenoma or carcinoma 2/50 25/50 39/50 44/50
|
Neoplastic Lesions
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Female |
Inhalation |
Pancreas Islet Cell
|
Clear Evidence |
Equivocal Evidence |
carcinoma 1/50 0/50 0/50 3/50
|
May Have Been Related
|
No
|
TR-581
|
7440-48-4 |
Cobalt |
Rats |
F344/NTac |
Male |
Inhalation |
Pancreas Islet Cell
|
Clear Evidence |
Clear Evidence |
adenoma or carcinoma 2/50 2/50 10/48 9/49
|
Neoplastic Lesions
|
Yes
|
TR-471
|
10026-24-1 |
Cobalt sulfate heptahydrate |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Equivocal Evidence |
BENIGN PHEOCHROMOCYTOMA 14/50 19/50 23/49 20/50, MALIGNANT PHEOCHROMOCYTOMA 0/50 2/50 2/49 2/50, OR COMPLEX PHEOCHROMOCYTOMA 1/50 0/50 1/49 0/50 COMBINED 15/50 19/50 25/49 20/50
|
May Have Been Related
|
Yes
|
TR-471
|
10026-24-1 |
Cobalt sulfate heptahydrate |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
BENIGN PHEOCHROMOCYTOMA 2/48 1/49 3/50 8/48, MALIGNANT PHEOCHROMOCYTOMA 0/48 0/49 1/50 1/48 OR COMPLEX PHEOCHROMOCYTOMA 0/48 0/49 0/50 1/48 COMBINED 2/48 1/49 4/50 10/48
|
Neoplastic Lesions
|
No
|
TR-471
|
10026-24-1 |
Cobalt sulfate heptahydrate |
Mice |
B6C3F1 |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 3/50 6/50 9/50 10/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 1/50 4/50 9/50 COMBINED 4/50 7/50 13/50 18/50
|
Neoplastic Lesions
|
No
|
TR-471
|
10026-24-1 |
Cobalt sulfate heptahydrate |
Mice |
B6C3F1 |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 9/50 12/50 13/50 18/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 4/50 5/50 7/50 11/50 COMBINED 11/50 14/50 19/50 28/50
|
Neoplastic Lesions
|
No
|
TR-471
|
10026-24-1 |
Cobalt sulfate heptahydrate |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 1/49 10/50 9/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 2/49 6/50 6/50 COMBINED 0/50 3/49 16/50 16/50
|
Neoplastic Lesions
|
No
|
TR-471
|
10026-24-1 |
Cobalt sulfate heptahydrate |
Rats |
F344/N |
Male |
Inhalation |
Lung
|
Some Evidence |
Some Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 1/50 4/50 1/48 6/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 0/50 3/48 1/50 COMBINED 1/50 4/50 4/48 7/50
|
Neoplastic Lesions
|
No
|
TR-513
|
91-17-8 |
Decalin |
Rats |
F344/N |
Female |
Inhalation |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
Yes
|
TR-513
|
91-17-8 |
Decalin |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
BENIGN OR MALIGNANT PHEOCHROMOCYTOMA 8/49 9/49 13/49 16/49 8/20
|
Neoplastic Lesions
|
No
|
TR-513
|
91-17-8 |
Decalin |
Rats |
F344/N |
Male |
Inhalation |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 1/50 2/50 6/49 9/50 5/20 ADENOMA OR CARCINOMA 1/50 3/50 7/49 12/50 6/20
|
Neoplastic Lesions
|
No
|
TR-513
|
91-17-8 |
Decalin |
Mice |
B6C3F1 |
Female |
Inhalation |
Liver
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA 7/49 13/50 8/50 17/50 CARCINOMA 4/49 16/50 6/50 5/50 COMBINED 11/49 27/50 14/50 20/50
|
May Have Been Related
|
No
|
TR-513
|
91-17-8 |
Decalin |
Mice |
B6C3F1 |
Female |
Inhalation |
Uterus/Cervix
|
Equivocal Evidence |
Equivocal Evidence |
STROMAL POLYP 0/49 0/50 2/50 3/50 STROMAL POLYP OR STROMAL SARCOMA 0/49 0/50 2/50 4/50
|
May Have Been Related
|
Yes
|
TR-402
|
110-00-9 |
Furan |
Mice |
B6C3F1 |
Female |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 2/50 1/50 6/50
|
Neoplastic Lesions
|
Yes
|
TR-402
|
110-00-9 |
Furan |
Mice |
B6C3F1 |
Male |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 1/49 6/50 10/50
|
Neoplastic Lesions
|
No
|
TR-402
|
110-00-9 |
Furan |
Rats |
F344/N |
Female |
Gavage |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
MONONUCLEAR CELL LEUKEMIA 8/50 9/50 17/50 21/50
|
Neoplastic Lesions
|
No
|
TR-402
|
110-00-9 |
Furan |
Rats |
F344/N |
Male |
Gavage |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
MONONUCLEAR CELL LEUKEMIA 8/50 11/50 17/50 25/50
|
Neoplastic Lesions
|
No
|
TR-402
|
110-00-9 |
Furan |
Mice |
B6C3F1 |
Female |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 5/50 31/50 48/50, CARCINOMA 2/50 7/50 27/50, COMBINED 7/50 34/50 50/50
|
Neoplastic Lesions
|
No
|
TR-402
|
110-00-9 |
Furan |
Mice |
B6C3F1 |
Male |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 20/50 33/50 42/50, CARCINOMA 7/50 32/50 34/50, COMBINED 26/50 44/50 50/50
|
Neoplastic Lesions
|
No
|
TR-402
|
110-00-9 |
Furan |
Rats |
F344/N |
Female |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 2/50 4/50 7/50, CARCINOMA 0/50 0/50 0/50 1/50, COMBINED 0/50 2/50 4/50 8/50; CHOLANGIOCARCINOMA 0/50 49/50 50/50 48/50
|
Neoplastic Lesions
|
No
|
TR-402
|
110-00-9 |
Furan |
Rats |
F344/N |
Male |
Gavage |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 1/50 4/50 18/50 27/50, CARCINOMA 0/50 1/50 6/50 18/50, COMBINED 1/50 5/50 22/50 35/50; CHOLANGIOCARCINOMA 0/50 43/50 48/50 49/50
|
Neoplastic Lesions
|
Yes
|
TR-492
|
1303-00-0 |
Gallium arsenide |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
BENIGN PHEOCHROMOCYTOMA 4/50 5/49 6/50 13/49
|
Neoplastic Lesions
|
No
|
TR-492
|
1303-00-0 |
Gallium arsenide |
Rats |
F344/N |
Female |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
MONONUCLEAR CELL LEUKEMIA 22/50 21/50 18/50 33/50
|
Neoplastic Lesions
|
No
|
TR-492
|
1303-00-0 |
Gallium arsenide |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/50 0/50 2/50 7/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 0/50 2/50 3/50 COMBINED 0/50 0/50 4/50 9/50
|
Neoplastic Lesions
|
Yes
|
TR-361
|
67-72-1 |
Hexachloroethane |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 15/50 28/45 21/49
|
May Have Been Related
|
No
|
TR-361
|
67-72-1 |
Hexachloroethane |
Rats |
F344/N |
Male |
Gavage |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 1/50 2/50 3/50 OR CARCINOMA 0/50 0/50 3/50 COMBINED 1/50 2/50 7/50
|
Neoplastic Lesions
|
No
|
TR-361
|
67-72-1 |
Hexachloroethane |
Rats |
F344/N |
Male |
Gavage |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
ADENOMA 0/50 0/50 1/50
|
Neoplastic Lesions
|
Yes
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
BENIGN PHEOCHROMOCYTOMA 2/50 6/48 2/50 9/49
|
Neoplastic Lesions
|
Yes
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
BENIGN PHEOCHROMOCYTOMA 10/50 22/50 16/49 23/50 BENIGN OR MALIGNANT PHEOCHROMOCYTOMA 10/50 26/50 18/49 24/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Female |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Equivocal Evidence |
MONONUCLEAR CELL LEUKEMIA 14/50 21/50 14/50 24/50
|
May Have Been Related
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Male |
Inhalation |
Hematopoietic System
|
Clear Evidence |
Equivocal Evidence |
MONONUCLEAR CELL LEUKEMIA 16/50 23/50 29/50 25/50
|
May Have Been Related
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Mice |
B6C3F1 |
Male |
Inhalation |
Intestines (Large)
|
Clear Evidence |
Equivocal Evidence |
CARCINOMA 0/50 1/50 5/50 3/50; ADEMONA OR CARCINOMA 1/50 2/50 6/50 3/50
|
May Have Been Related
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Mice |
B6C3F1 |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 12/50 14/50 18/50 14/50; CARCINOMA 6/50 17/50 8/50 10/50; COMBINED 18/50 28/50 24/50 23/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Mice |
B6C3F1 |
Male |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 17/50 24/50 23/50 32/50; CARCINOMA 11/50 22/50 23/50 16/50; COMBINED 26/50 40/50 37/50 39/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Mice |
B6C3F1 |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADEMONA 3/50 6/50 10/50 7/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 6/50 5/50 7/50; COMBINED 4/50 11/50 15/50 14/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Mice |
B6C3F1 |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR CARCINOMA 6/50 15/50 22/50 13/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADEMONA 0/50 7/50 5/50 19/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 3/50 1/50 11/50; COMBINED 1/50 10/50 6/50 26/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADEMONA 6/50 13/50 27/50 30/50; ALVEOLAR/BRONCHIOLAR CARCINOMA 1/50 10/50 8/50 16/50; COMBINED 7/50 22/50 30/50 35/50; SQUAMOUS CELL CARCINOMA 0/50 0/50 0/50 4/50
|
Neoplastic Lesions
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Female |
Inhalation |
Mammary Gland
|
Clear Evidence |
Equivocal Evidence |
CARCINOMA 0/50 8/50 3/50 2/50
|
May Have Been Related
|
No
|
TR-499
|
22398-80-7 |
Indium phosphide |
Rats |
F344/N |
Male |
Inhalation |
Skin
|
Clear Evidence |
Equivocal Evidence |
FIBROMA 1/50 4/50 7/50 3/50; FIBROMA OR FIBROSARCOMA 2/50 4/50 8/50 4/50
|
May Have Been Related
|
Yes
|
TR-313
|
2385-85-5 |
Mirex |
Rats |
F344/N |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 8/51 7/52 13/52 11/52 18/51 19/51
|
Neoplastic Lesions
|
No
|
TR-313
|
2385-85-5 |
Mirex |
Rats |
F344/N |
Female |
Dosed-Feed |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
LEUKEMIA 6/52 9/52 14/52
|
Neoplastic Lesions
|
No
|
TR-313
|
2385-85-5 |
Mirex |
Rats |
F344/N |
Male |
Dosed-Feed |
Kidney Transitional Cell
|
Clear Evidence |
Clear Evidence |
PAPILLOMA 0/51 0/51 0/52 0/52 1/51 3/52
|
Neoplastic Lesions
|
No
|
TR-313
|
2385-85-5 |
Mirex |
Rats |
F344/N |
Female |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
NEOPLASTIC NODULE 2/52 23/52 30/52
|
Neoplastic Lesions
|
No
|
TR-313
|
2385-85-5 |
Mirex |
Rats |
F344/N |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
NEOPLASTIC NODULE 3/52 5/52 5/52 14/52 15/52 26/52
|
Neoplastic Lesions
|
Yes
|
TR-451
|
1313-99-1 |
Nickel (II) oxide |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 4/51 7/52 6/53 18/53
|
Neoplastic Lesions
|
Yes
|
TR-451
|
1313-99-1 |
Nickel (II) oxide |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 27/54 24/52 26/53 32/52 OR MALIGNANT PHEOCHROMOCYTOMA 0/54 0/52 1/53 6/52 COMBINED 27/54 24/52 27/53 35/52
|
Neoplastic Lesions
|
No
|
TR-451
|
1313-99-1 |
Nickel (II) oxide |
Mice |
B6C3F1 |
Female |
Inhalation |
Lung
|
Equivocal Evidence |
Equivocal Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 2/64 4/66 10/63 3/64 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 4/64 11/66 4/63 5/64 COMBINED 6/64 15/66 12/63 8/64
|
Neoplastic Lesions
|
No
|
TR-451
|
1313-99-1 |
Nickel (II) oxide |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Some Evidence |
Some Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 1/53 0/53 1/53 4/54 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/53 0/53 5/53 1/54 COMBINED 1/53 0/53 6/53 5/54
|
Neoplastic Lesions
|
No
|
TR-451
|
1313-99-1 |
Nickel (II) oxide |
Rats |
F344/N |
Male |
Inhalation |
Lung
|
Some Evidence |
Some Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/54 1/53 3/53 2/52 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/54 0/53 3/53 2/52 OR SQUAMOUS CELL CARCINOMA 1/54 0/53 0/53 0/52 COMBINED 1/54 1/53 6/53 4/52
|
Neoplastic Lesions
|
Yes
|
TR-453
|
12035-72-2 |
Nickel subsulfide |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 2/53 7/53 36/53
|
Neoplastic Lesions
|
Yes
|
TR-453
|
12035-72-2 |
Nickel subsulfide |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 13/53 30/52 38/53 OR MALIGNANT PHEOCHROMOCYTOMA 0/53 2/52 10/53 COMBINED 14/53 30/52 38/53
|
Neoplastic Lesions
|
No
|
TR-453
|
12035-72-2 |
Nickel subsulfide |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 2/53 5/53 5/53 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/53 3/53 6/53 OR SQUAMOUS CELL CARCINOMA 0/53 1/53 0/53 COMBINED 2/53 6/53 9/53
|
Neoplastic Lesions
|
No
|
TR-453
|
12035-72-2 |
Nickel subsulfide |
Rats |
F344/N |
Male |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 0/53 3/53 6/53; ALVEOLAR/BRONCHIOLAR CARCINOMA 0/53 3/53 6/53; ALVEOLAR/BRONCHIOLAR ADENOMA OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/53 6/53 11/53
|
Neoplastic Lesions
|
Yes
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Rats |
Harlan Sprague-Dawley |
Female |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
benign pheochromocytoma (0/49, 3/50, 4/50, 6/50)
|
Neoplastic Lesions
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Mice |
B6C3F1 |
Female |
Inhalation |
Harderian Gland
|
Clear Evidence |
Clear Evidence |
adenoma (2/50, 6/50, 6/50, 8/50); adenoma or adenocarcinoma (2/50, 6/50, 9/50, 8/50)
|
Neoplastic Lesions
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Mice |
B6C3F1 |
Female |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular adenoma (12/50, 14/50, 24/50, 34/50); hepatocellular carcinoma (7/50, 8/50, 12/50, 34/50); hepatoblastoma (0/50, 0/50, 1/50, 8/50)
|
Neoplastic Lesions
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Mice |
B6C3F1 |
Male |
Inhalation |
Liver
|
Clear Evidence |
Clear Evidence |
hepatocellular carcinoma (8/50, 19/50, 16/50, 35/50); hepatoblastoma (1/50, 1/50, 1/50, 15/50)
|
Neoplastic Lesions
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Rats |
Harlan Sprague-Dawley |
Male |
Inhalation |
Lung
|
Some Evidence |
Equivocal Evidence |
alveolar/bronchiolar adenoma or carcinoma (0/50, 2/50, 0/50, 3/50)
|
May Have Been Related
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Rats |
Harlan Sprague-Dawley |
Female |
Inhalation |
Thyroid Gland C-Cell
|
Some Evidence |
Some Evidence |
adenoma (2/50, 8/50, 8/50, 14/50)
|
Neoplastic Lesions
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Rats |
Harlan Sprague-Dawley |
Male |
Inhalation |
Thyroid Gland C-Cell
|
Some Evidence |
Some Evidence |
adenoma (2/50, 5/49, 3/49, 12/50)
|
Neoplastic Lesions
|
No
|
TR-594
|
98-56-6 |
p-Chloro-a,a,a-trifluorotoluene |
Rats |
Harlan Sprague-Dawley |
Female |
Inhalation |
Uterus
|
Some Evidence |
Some Evidence |
adenocarcinoma (1/50, 1/50, 0/50, 5/50); stromal polyp (7/50, 9/50, 16/50, 12/50)
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Female |
Gavage |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
Yes
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Clear Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 13/49 14/48 15/48 26/49
|
May Have Been Related
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Female |
Gavage |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
PHEOCHROMOCYTOMA 2/50 3/50 1/50 6/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Liver
|
Some Evidence |
Some Evidence |
ADENOMA 9/50 15/49 10/50 44/50 OR CARCINOMA 3/50 7/49 11/50 17/50 COMBINED 11/50 21/49 20/50 21/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Male |
Gavage |
Spleen
|
Clear Evidence |
Clear Evidence |
FIBROSARCOMA 0/49 1/50 2/50 17/50, HEMANGIOSARCOMA 0/49 0/50 0/50 4/50, OR OSTEOSARCOMA 0/49 0/50 1/50 19/50 COMBINED 0/49 1/50 3/50 38/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Rats |
F344/N |
Female |
Gavage |
Spleen
|
Equivocal Evidence |
Equivocal Evidence |
FIBROSARCOMA 0/50 0/50 1/50 0/50 OR OSTEOSARCOMA 0/50 0/50 0/50 1/50 COMBINED 0/50 0/50 1/50 1/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 2/50 2/50 1/49 6/50
|
Neoplastic Lesions
|
No
|
TR-351
|
20265-96-7 |
p-Chloroaniline hydrochloride |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Spleen)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 3/50 2/47 0/49 5/49
|
Neoplastic Lesions
|
No
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Rats |
F344/N |
Female |
Gavage |
Adrenal Gland Medulla
|
Equivocal Evidence |
Equivocal Evidence |
Pheochromocytoma 3/50 7/50 9/50
|
Neoplastic Lesions
|
Yes
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Mice |
B6C3F1 |
Male |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
Pheochromocytoma 0/50 4/50 7/48
|
Neoplastic Lesions
|
Yes
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Rats |
F344/N |
Male |
Gavage |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
Pheochromocytoma 12/50 17/50 23/50 15/48 or malignant pheochromocytoma 3/50 2/50 4/50 0/48 combined 15/50 18/50 25/50 15/48
|
Neoplastic Lesions
|
No
|
TR-414
|
1825-21-4 |
Pentachloroanisole |
Mice |
B6C3F1 |
Male |
Gavage |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
Hemangiosarcoma 2/50 8/50 10/50
|
Neoplastic Lesions
|
Yes
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 0/35 2/49 2/46 38/49
|
Neoplastic Lesions
|
Yes
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 0/34 4/48 21/48 44/49 OR MALIGNANT PHEOCHROMOCYTOMA 1/34 0/48 0/48 3/49 COMBINED 1/34 4/48 21/48 45/49
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 1/34 3/50 6/49 30/48 OR CARCINOMA 0/34 1/50 0/49 1/48 COMBINED 1/34 4/50 6/49 31/48
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 5/35 13/48 17/48 32/49 OR CARCINOMA 1/35 7/48 7/48 9/49 COMBINED 6/35 19/48 21/48 34/49
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Liver)
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/34 1/50 1/49 8/48
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, Dowicide EC-7 |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Spleen)
|
Clear Evidence |
Clear Evidence |
HEMANGIOSARCOMA 0/34 0/50 2/50 2/47
|
Neoplastic Lesions
|
Yes
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 0/31 10/45 23/45
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Liver
|
Clear Evidence |
Clear Evidence |
ADENOMA 5/32 20/47 33/48 OR CARCINOMA 2/32 10/47 12/48 COMBINED 7/32 26/47 37/48
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Liver
|
Some Evidence |
Some Evidence |
ADENOMA 3/33 8/49 8/50 OR CARCINOMA 0/33 1/49 1/50 COMBINED 3/33 9/49 9/50
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Liver)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 0/33 2/49 4/50
|
Neoplastic Lesions
|
No
|
TR-349
|
87-86-5 |
Pentachlorophenol, technical |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Vascular System (Spleen)
|
Some Evidence |
Some Evidence |
HEMANGIOSARCOMA 0/33 1/50 3/47
|
Neoplastic Lesions
|
Yes
|
TR-465
|
77-09-8 |
Phenolphthalein |
Rats |
F344/N |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 17/50 34/50 34/50 34/50
|
Neoplastic Lesions
|
Yes
|
TR-465
|
77-09-8 |
Phenolphthalein |
Rats |
F344/N |
Female |
Dosed-Feed |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 3/50 11/50 9/50 2/49 OR MALIGNANT PHEOCHROMOCYTOMA 0/50 1/50 1/50 0/50 COMBINED 3/50 12/50 10/50 2/49
|
Neoplastic Lesions
|
No
|
TR-465
|
77-09-8 |
Phenolphthalein |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
HISTIOCYTIC SARCOMA 0/50 2/50 7/50 7/50; LYMPHOMA 15/50 28/50 33/5 25/50; LYMPHOMA (THYMIC ORIGIN) 1/50 9/50 10/50 7/50
|
Neoplastic Lesions
|
No
|
TR-465
|
77-09-8 |
Phenolphthalein |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Hematopoietic System
|
Clear Evidence |
Clear Evidence |
HISTIOCYTIC SARCOMA 1/50 3/50 11/50 12/49; LYMPHOMA (THYMIC ORIGIN) 0/50 4/50 7/50 2/49
|
Neoplastic Lesions
|
No
|
TR-465
|
77-09-8 |
Phenolphthalein |
Rats |
F344/N |
Male |
Dosed-Feed |
Kidney Tubular Cell
|
Clear Evidence |
Clear Evidence |
(SINGLE SECTIONS) ADENOMA 0/50 4/50 2/50 6/50 OR CARCINOMA 0/50 1/50 1/50 2/50 COMBINED 0/50 5/50 3/50 7/50; (SINGLE AND STEP SECTIONS) ADENOMA 1/50 10/50 15/50 15/50 OR CARCINOMA 0/50 1/50 2/50 2/50 COMBINED 1/50 10/50 16/50 16/50
|
Neoplastic Lesions
|
No
|
TR-465
|
77-09-8 |
Phenolphthalein |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Ovary
|
Clear Evidence |
Clear Evidence |
BENIGN SEX-CORD STROMAL TUMOR 0/50 7/49 6/50 5/50
|
Neoplastic Lesions
|
No
|
TR-193
|
50-55-5 |
Reserpine |
Rats |
F344/N |
Female |
Dosed-Feed |
Unspecified
|
Negative |
|
Not applicable
|
Not applicable
|
Yes
|
TR-193
|
50-55-5 |
Reserpine |
Rats |
F344/N |
Male |
Dosed-Feed |
Adrenal Gland Medulla
|
Positive |
Positive |
PHEOCHROMOCYTOMA
|
Neoplastic Lesions
|
No
|
TR-193
|
50-55-5 |
Reserpine |
Mice |
B6C3F1 |
Female |
Dosed-Feed |
Mammary Gland
|
Positive |
Positive |
(FIBROADENOMA, ADENOCARCINOMA, ADENOSQUAMOUS CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-193
|
50-55-5 |
Reserpine |
Mice |
B6C3F1 |
Male |
Dosed-Feed |
Seminal Vesicle
|
Positive |
Positive |
(CARCINOMA)
|
Neoplastic Lesions
|
No
|
TR-519
|
64742-88-7 |
Stoddard solvent (type lIC) |
Mice |
B6C3F1 |
Male |
Inhalation |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
No
|
TR-519
|
64742-88-7 |
Stoddard solvent (type lIC) |
Rats |
F344/N |
Female |
Inhalation |
Unspecified
|
No Evidence |
|
Not applicable
|
Not applicable
|
Yes
|
TR-519
|
64742-88-7 |
Stoddard solvent (type lIC) |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
BENIGN PHEOCHROMOCYTOMA 5/50 9/50 13/50 17/50 BENIGN OR MALIGNANT PHEOCHROMOCYTOMA 6/50 9/50 13/50 19/50
|
Neoplastic Lesions
|
No
|
TR-519
|
64742-88-7 |
Stoddard solvent (type lIC) |
Rats |
F344/N |
Male |
Inhalation |
Kidney Tubular Cell
|
Some Evidence |
Equivocal Evidence |
(STANDARD AND EXTENDED EVALUATION COMBINED) ADENOMA 3/50 2/50 3/50 7/50
|
May Have Been Related
|
No
|
TR-519
|
64742-88-7 |
Stoddard solvent (type lIC) |
Mice |
B6C3F1 |
Female |
Inhalation |
Liver
|
Equivocal Evidence |
Equivocal Evidence |
ADENOMA 9/50 12/50 15/50 18/50
|
May Have Been Related
|
Yes
|
TR-421
|
14807-96-6 |
Talc |
Rats |
F344/N |
Female |
Inhalation |
Adrenal Gland Medulla
|
Clear Evidence |
Clear Evidence |
PHEOCHROMOCYTOMA 13/48 14/47 18/49 OR MALIGNANT PHEOCHROMOCYTOMA 0/48 1/47 10/49 COMBINED 13/48 14/47 23/49
|
Neoplastic Lesions
|
Yes
|
TR-421
|
14807-96-6 |
Talc |
Rats |
F344/N |
Male |
Inhalation |
Adrenal Gland Medulla
|
Some Evidence |
Some Evidence |
PHEOCHROMOCYTOMA 25/49 30/48 36/47 OR MALIGNANT PHEOCHROMOCYTOMA 3/49 3/48 7/47 COMBINED 26/49 32/48 37/47
|
Neoplastic Lesions
|
No
|
TR-421
|
14807-96-6 |
Talc |
Rats |
F344/N |
Female |
Inhalation |
Lung
|
Clear Evidence |
Clear Evidence |
ALVEOLAR/BRONCHIOLAR ADENOMA 1/50 0/48 9/50 OR ALVEOLAR/BRONCHIOLAR CARCINOMA 0/50 0/48 5/50 COMBINED 1/50 0/48 13/50
|
Neoplastic Lesions
|